Cusack Catherine 4

What Happened

• Catherine Cusack, a director of Sabra Health Care REIT (SBRA), was credited with 781 stock units (transaction code A — award/acquisition) on 2026-02-27 at $0.00. These were dividend-equivalent stock units — not an open-market purchase or sale — and no cash was paid.
• The filing notes these units are dividend equivalents calculated on the market value of SBRA common stock on the dividend payment date and will vest and be payable on the same terms as the underlying stock units.

Key Details

• Transaction date: 2026-02-27; Filing date: 2026-03-03 (no late-filing flag shown in the filing).
• Price: $0.00 per unit (dividend-equivalent award).
• Units referenced in the filing: 781 newly credited units; filing also shows 2,854 unvested stock units and 51,345 units that have vested but whose payment has been deferred. Each stock unit represents the right to receive one share.
• Footnotes: F1 = dividend-equivalent payments on previously granted stock units; F2 = breakdown of unvested and vested-but-deferred units.
• Transaction type: Award/Grant (A) — routine compensation/benefit for an insider, not a buy/sell trade.

Context

• These are dividend-equivalent stock units tied to prior awards and will vest/pay out under the original grant terms; they do not represent a market purchase or sale and therefore are not a direct signal of buying/selling intent.
• For retail investors, such awards are common as part of director compensation and primarily reflect compensation mechanics rather than immediate changes in insider sentiment.